Prognostic value of diffuse cancer inflammation index (ALI), serum neutrophil/lymphocyte (NLR) and platelet/lymphocyte (PLR) in advanced-stage lung cancer
Yazarlar (4)
Aysen Evkan Ozturk
Berna Komurcuoglu
Gamze Kaplan Karakurt
Prof. Dr. Özgür ÖZTÜRK Kastamonu Üniversitesi, Türkiye
| Makale Türü | Özgün Makale (Uluslararası alan indekslerindeki dergilerde yayınlanan tam makale) | ||
| Dergi Adı | Journal of Cancer Research and Therapeutics | ||
| Makale Dili | – | Basım Tarihi | 04-2024 |
| Cilt / Sayı / Sayfa | 20 / 3 / 893–897 | DOI | – |
| Makale Linki | https://journals.lww.com/cancerjournal/fulltext/2024/20030/prognostic_value_of_diffuse_cancer_inflammation.25.aspx | ||
| UAK Araştırma Alanları |
Süper İletkenler
|
||
| Özet |
| Method:One hundred fifteen patients with locally advanced and advanced lung cancer who were diagnosed in our chest diseases clinic between 2013 and 2015 were retrospectively analyzed. The relationship between advanced lung cancer inflammation index (ALI index), serum neutrophil/lymphocyte ratio (NLR), and platelet/lymphocyte ratio (PLR) levels at the time of diagnosis were calculated, and their relationship with overall survival (OS), disease-free survival, and the treatment response and their effect on predicting prognosis were investigated.Findings:When the ALI value was examined in the group with non-small cell lung, the OS was found to be 9.018 months in the group over 18 years of age and it was 3.78 months in the group below. Low ALI index was significantly associated with short survival (P<. 05). When the NLR values were examined in the entire patient group, OS more than 5 was 5.95 months … |
| Anahtar Kelimeler |
